T0	Disease 60 67	obesity
#1	AnnotatorNotes T0	DOID:9970
T12	Chemical 397 416	phosphatidylcholine
T13	Chemical 440 464	phosphatidylethanolamine
T14	Chemical 473 492	Phosphatidylcholine
T15	Chemical 539 552	triglycerides
T16	Chemical 595 614	phosphatidylcholine
T17	Chemical 711 724	triglycerides
T19	Chemical 774 787	triglycerides
T20	Chemical 808 821	cystathionine
T22	Disease 872 892	hyperhomocysteinemia
#15	AnnotatorNotes T22	DOID:9279
T23	Chemical 909 921	homocysteine
T24	Chemical 1058 1077	phosphatidylcholine
T27	Chemical 1295 1301	folate
T3	Biomarker 127 130	CFD
T30	Chemical 1386 1396	fatty acid
T31	Disease 1456 1459	CFD
T34	Disease 1640 1658	insulin resistance
#24	AnnotatorNotes T34	D007333
T35	Disease 1680 1683	CFD
T36	Biomarker 1720 1723	CFD
T37	Disease 1732 1758	lipid metabolism disorders
T38	Disease 1784 1802	insulin resistance
T4	Disease 143 169	lipid metabolism disorders
#29	AnnotatorNotes T4	DOID:3146
T5	Chemical 194 200	folate
T6	Chemical 205 224	phosphatidylcholine
T7	Chemical 283 289	folate
T9	Chemical 324 348	phosphatidylethanolamine
R1	Risk-Factor Arg1:T3 Arg2:T4	
T18	Drug 83 112	treatment of folate deficient
#2	AnnotatorNotes T18	not found
R2	Causes Arg1:T18 Arg2:T0	
T2	Gene-Protein 324 368	phosphatidylethanolamine N-methyltransferase
T10	Chemical 517 521	VLDL
T11	Biomarker 585 621	decreased phosphatidylcholine levels
T25	Biomarker 640 678	reduction of VLDL in the liver tissues
T28	Chemical 653 657	VLDL
T29	Biomarker 687 724	accumulation of hepatic triglycerides
T33	Biomarker 758 803	increased serum triglycerides and VLDL levels
T39	Chemical 792 796	VLDL
T40	Gene-Protein 808 835	cystathionine beta-synthase
T41	Biomarker 894 928	elevated serum homocysteine levels
T42	Chemical 953 957	VLDL
T43	Biomarker 982 1008	elevated serum VLDL levels
T44	Chemical 997 1001	VLDL
T8	Biomarker 1052 1077	lower phosphatidylcholine
T21	Gene-Protein 1087 1093	Srebp1
T45	Gene-Protein 1159 1163	Acc1
T46	Gene-Protein 1168 1172	Fasn
T47	Gene-Protein 1341 1345	Fasn
T48	Gene-Protein 1409 1413	Cd36
T49	Disease 1368 1371	CFD
#3	AnnotatorNotes T49	not found
T50	Biomarker 1589 1615	hepatic lipid accumulation
T51	Chemical 1597 1602	lipid
T52	Collection 1640 1683	insulin resistance, was observed in the CFD
R3	Association Arg1:T50 Arg2:T52	
R4	Association Arg1:T36 Arg2:T53	
T53	Collection 1732 1802	lipid metabolism disorders, which may be related to insulin resistance
T26	Gene-Protein 1640 1647	insulin
#4	AnnotatorNotes T26	HGNC:6081
T54	Gene-Protein 1784 1791	insulin
T1	Biomarker 1460 1498	increased hepatic fatty acid synthesis
T32	Biomarker 808 845	cystathionine beta-synthase-deficient
R5	Association Arg1:T32 Arg2:T22	
